FHIR Release 3 (STU) CI-Build

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0 . For a full list Continuous Integration Build of available versions, see FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions . Page versions: R5 R4B R4 R3 R2

Medicationdispenseexample8

Example MedicationDispense/meddisp008 (Narrative)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Ballot Standards Status : Informative Compartments : Encounter , Group , Patient , Practitioner

This is the narrative for the resource. See also the XML or , JSON or Turtle format. This example conforms to the profile MedicationDispense .

Generated Narrative with Details Narrative: MedicationDispense meddisp008

id status : meddisp008 Completed

Medications

- Reference
* Medication capecitabine 500 MG Oral Tablet [Xeloda]

contained subject : Donald Duck

Performers

- Actor
* Practitioner Rob van den Berk (official)

authorizingPrescription : MedicationRequest: identifier = http://www.bmc.nl/portal/prescriptions#12345689 (use: official, ); status = active; intent = order; authoredOn = 2015-01-15

dosageInstruction

sequence : completed 1

medication timing : id: medexample015; Capecitabine 500mg oral tablet (Xeloda) (Details : {RxNorm code '213293' = '213293', given as 'Capecitabine 500mg oral tablet (Xeloda)'}) ; isBrand 2 per 21 days

subject route : Donald Duck oral administration of treatment

Performers DoseAndRates

- Actor Type OnBehalfOf Dose[x]
* Practitioner/f006 Ordered Organization/2.16.840.1.113883.19.5 500 mg (Details: UCUM codemg = 'mg')

authorizingPrescription : MedicationRequest/medrx0309 Generated Narrative: Medication #medexample015

dosageInstruction code : capecitabine 500 MG Oral Tablet [Xeloda]

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.